Trial intelligence / Profile preview

S-QLB3 vs ITM in Laparoscopic Nephrectomy

NCT06630858Completed

Sponsor
Ondokuz Mayıs University
Start
Oct 2024
Primary completion
Apr 2025
Countries
1
01

Overview

Randomised, single-blind trial (2 arms), sponsored by Ondokuz Mayıs University. Primary endpoint: Cumulative equivalent morphine consumption in the first 24 hours after surgery. Started Oct 2024; status: completed.

Beyond the preview

Go deeper on NCT06630858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06630858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call